「上部尿路癌におけるStromal antigen 2 (STAG2) 発現喪失の臨床病理学的意義と尿路上皮癌におけるその機能に関する研究」の関連論文
-
Investigation of therapeutic target of DNMT3A-mutant acute myeloid leukemia
-
膵神経内分泌腫瘍におけるクロマチンリモデリング因子異常と腫瘍進展・予後との関連
-
Epidemiology of Japanese patients with atypical hemolytic uremic syndrome, and characteristics of patients with anti-CFH antibodies
-
肺腺癌における転写因子ASCL1の機能解析
-
Expression of hemoglobin beta is associated with poor prognosis and aggressive phenotypes in clear cell renal cell carcinoma
-
Characterization of Dclk1 isoforms in the developing mouse brain
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
内分泌療法耐性乳癌におけるL型アミノ酸トランスポーター1 (LAT1)を介した代謝変化を標的とした治療戦略の確立
-
Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN-amplified neuroblastoma cells
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
CARD9の肺腺がんの新しい予後因子としての可能性
-
イヌの移行上皮癌におけるhuman epidermal growth factor receptor2(HER2)を標的とした新規治療法に関する研究
-
マルチリージョンシークエンスを用いた腫瘍内不均一性と腫瘍進化の過程の解析
-
大腸鋸歯状腺腫の内視鏡及び網羅的遺伝子発現解析による検討
-
膵管内乳頭粘液性腫瘍由来浸潤癌と通常型膵癌の差異の検討
-
Differential effects of sevoflurane on the growth and apoptosis of human cancer cell lines
-
Identification and Functional Analysis of Genes Critical to Tumorigenesis
-
The roles of adipose-tissue and malignant ascites in the development of peritoneal metastasis and the progression of ovarian cancer
-
Human Papillomavirus [HPV] 16,18,52,58型における子宮頸癌発癌形式の検討
-
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF‐β signaling
-
The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness
-
神経線維腫症2型の臨床的・遺伝的背景の解析
-
Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator
-
Trefoil factor family 2 inhibits cholangiocarcinogenesis by regulating the PTEN pathway in mice
-
BEX2は肝細胞がんにおける予後不良因子でありがん幹細胞形質の維持に必要である
-
ヒストン修飾を標的とした卵巣明細胞癌の新規治療薬の開発
-
胃癌におけるクロマチン修飾因子BRD4及びポリコーム抑制因子EZH2の臨床病理学的検討
-
High RAD18 expression is associated with disease progression and poor prognosis in patients with gastric cancer
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
消化管癌における分泌型プロテアーゼの発現異常と悪性形質との関連
-
SMAD4発現保持とRUNX3発現喪失は膵管癌予後不良因子となる
-
骨軟部肉腫の薬剤感受性に関与するlong non-coding RNAの研究
-
The discovery of PKCγ as a novel sleep-regulating element and analysis of its phosphorylation signaling.
-
H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
-
Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor
-
高齢MRP4欠損マウス網膜における遺伝子発現プロファイリングと表現型の変化
-
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas
-
マルファン症候群の大動脈におけるマクロファージの関与、および遺伝子型と臨床像の解析
-
胃がんにおける腫瘍内免疫応答の解析
-
腫瘍幹細胞を含む頭蓋底脊索腫細胞に対するSignal transducer and activator of transcription (STAT) 3 抑制による細胞増殖抑制効果の検討
-
Identification of perturbed pathways and biological processes due to growth hormone (GH) excess : insights into the cellular integrity of genetically modified (GMO) fish and acromegaly
-
Adverse Effect of Circadian Rhythm Disorder on Reparative Angiogenesis in Hind Limb Ischemia
-
PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer
-
膵癌における腫瘍浸潤リンパ球と患者の生存に関連した三次リンパ組織の統合分析
-
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
-
骨肉腫と免疫細胞の相互作用の解明による骨肉腫に対する新規治療標的の探索
-
がん幹細胞性の維持に寄与する因子の解析
-
Studies on TP53 gene mutations in canine histiocytic sarcoma
-
Prognostic value of somatic mutations at remission in acute myeloid leukemia
-
Unique miRNA profiling of squamous cell carcinoma arising from ovarian mature teratoma: comprehensive miRNA sequence analysis of its molecular background